Evidence map›Paper›PMID 25451487›Full record

Trial reportThe Journal of thoracic and cardiovascular surgery2015

Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction.

Tomasz Kukulski, Lilin She, Normand Racine, Sinisa Gradinac, Julio A Panza, Eric J Velazquez, Kwan Chan, Mark C Petrie, Kerry L Lee, Patricia A Pellikka and 9 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of thoracic and cardiovascular surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology.Journal of molecular medicine (Berlin, Germany) · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. CoQNutrition & metabolism · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Tomasz KukulskiDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Disease, Medical University of Silesia, Zabrze, Poland. Electronic address: tomasz.kukulski@sccs.pl.
Lilin SheDuke Clinical Research Institute, Durham, NC.
Normand RacineDepartment of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Canada.
Sinisa GradinacDedinje Cardiovascular Institute, Belgrade, Serbia.
Julio A PanzaWestchester Medical Center, New York, NY.
Eric J VelazquezDuke Clinical Research Institute, Durham, NC; Department of Medicine-Cardiology, Duke University School of Medicine, Durham, NC.
Kwan ChanUniversity of Ottawa Heart Institute, Ottawa, Canada.
Mark C PetrieGlasgow Royal Infirmary, Glasgow, United Kingdom.
Kerry L LeeDuke Clinical Research Institute, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC.
Patricia A PellikkaDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn.
Alexander RomanovResearch Institute of Circulation Pathology, Novosibirsk, Russia.
Jolanta BiernatMedical University of Silesia, Katowice, Poland.
Jean L RouleauDepartment of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Canada.
Carmen BatlleCasa De Galicia, Montevideo, Uruguay.
Jan RogowskiMedical University of Gdansk, Gdansk, Poland.
Paolo FerrazziOspedali Riuniti Di Bergamo, Bergamo, Italy.
Marian ZembalaDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Disease, Medical University of Silesia, Zabrze, Poland.
Jae K OhDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn.
Surgical Treatment for Ischemic Heart Failure Investigators

Funding

STICH Trial-Coordinating CenterU01HL069015 · NHLBI · DUKE UNIVERSITY · PI JONES, ROBERT H · 2002 to 2011
$27.3M
STICHESR01HL105853 · NHLBI · DUKE UNIVERSITY · PI AL-KHALIDI, HUSSEIN · 2011 to 2015
$10.2M
STICH Trial-Statistical and Data Coordinatiing CenterU01HL069013 · NHLBI · DUKE UNIVERSITY · PI LEE, KERRY L · 2002 to 2010
$5.0M
STICH Trial-Echocardiographic Core LaboratoryU01HL069010 · NHLBI · MAYO CLINIC ROCHESTER · PI OH, JAE K · 2002 to 2007
$1.4M
NHLBI NIH HHS R01 HL105853NHLBI NIH HHS U01 HL069010NHLBI NIH HHS U01 HL069013NHLBI NIH HHS U01 HL069015NHLBI NIH HHS U01HL69010NHLBI NIH HHS U01HL69013NHLBI NIH HHS U01HL69015
6 · The paper itself

Abstract

objectiveWhether right ventricular dysfunction affects clinical outcome after coronary artery bypass grafting with or without surgical ventricular reconstruction is still unknown. The aim of the study was to assess the impact of right ventricular dysfunction on clinical outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction.

methodsOf 1000 patients in the Surgical Treatment for Ischemic Heart Failure with coronary artery disease, left ventricular ejection fraction 35% or less, and anterior dysfunction, who were randomized to undergo coronary artery bypass grafting or coronary artery bypass grafting + surgical ventricular reconstruction, baseline right ventricular function could be assessed by echocardiography in 866 patients. Patients were followed for a median of 48 months. All-cause mortality or cardiovascular hospitalization was the primary end point, and all-cause mortality alone was a secondary end point.

resultsRight ventricular dysfunction was mild in 102 patients (12%) and moderate or severe in 78 patients (9%). Moderate to severe right ventricular dysfunction was associated with a larger left ventricle, lower ejection fraction, more severe mitral regurgitation, higher filling pressure, and higher pulmonary artery systolic pressure (all P < .0001) compared with normal or mildly reduced right ventricular function. A significant interaction between right ventricular dysfunction and treatment allocation was observed. Patients with moderate or severe right ventricular dysfunction who received coronary artery bypass grafting + surgical ventricular reconstruction had significantly worse outcomes compared with patients who received coronary artery bypass grafting alone on both the primary (hazard ratio, 1.86; confidence interval, 1.06-3.26; P = .028) and the secondary (hazard ratio, 3.37; confidence interval, 1.36-8.37; P = .005) end points. After adjusting for all other prognostic clinical factors, the interaction remained significant with respect to all-cause mortality (P = .022).

conclusionsAdding surgical ventricular reconstruction to coronary artery bypass grafting may worsen long-term survival in patients with ischemic cardiomyopathy with moderate to severe right ventricular dysfunction, which reflects advanced left ventricular remodeling.

Indexed as

Coronary Artery BypassPlastic Surgery ProceduresVentricular Function, RightAgedCardiomyopathiesCoronary Artery DiseaseFemaleHeart VentriclesHumansKaplan-Meier EstimateMaleMiddle AgedPatient ReadmissionProportional Hazards ModelsRisk FactorsSeverity of Illness Index

Identifiers

PMID25451487
PMCPMC4385741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.